| Title |
Unintended consequences of reducing QT-alert overload in a computerized physician order entry system
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, May 2009
|
| DOI | 10.1007/s00228-009-0654-3 |
| Pubmed ID | |
| Authors |
Heleen van der Sijs, Ravi Kowlesar, Jos Aarts, Marc Berg, Arnold Vulto, Teun van Gelder |
| Abstract |
After complaints of too many low-specificity drug-drug interaction (DDI) alerts on QT prolongation, the rules for QT alerting in the Dutch national drug database were restricted in 2007 to obviously QT-prolonging drugs. The aim of this virtual study was to investigate whether this adjustment would improve the identification of patients at risk of developing Torsades de Pointes (TdP) due to QT-prolonging drug combinations in a computerized physician order entry system (CPOE) and whether these new rules should be implemented. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 3% |
| Saudi Arabia | 2 | 3% |
| Netherlands | 1 | 2% |
| Colombia | 1 | 2% |
| Canada | 1 | 2% |
| Unknown | 52 | 88% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 12 | 20% |
| Researcher | 11 | 19% |
| Student > Master | 7 | 12% |
| Student > Postgraduate | 6 | 10% |
| Other | 5 | 8% |
| Other | 16 | 27% |
| Unknown | 2 | 3% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 46% |
| Computer Science | 9 | 15% |
| Nursing and Health Professions | 6 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
| Agricultural and Biological Sciences | 4 | 7% |
| Other | 5 | 8% |
| Unknown | 3 | 5% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2014.
All research outputs
#20,947,998
of 25,728,855 outputs
Outputs from European Journal of Clinical Pharmacology
#2,398
of 2,775 outputs
Outputs of similar age
#96,261
of 104,400 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#9
of 9 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,775 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,400 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.